Expression and regulation of galectin 3 in rat osteoblastic cells
Authors:
- 1 December 1996
- journal article
- research article
- Published by Wiley in Journal of Cellular Physiology
- Vol. 169 (3) , 468-480
Abstract
Galectin 3 is an endogenous soluble β-galactoside-specific lectin originally identified and termed ηBP or IgE-binding protein in rat basophilic leukemia cells, but its wide tissue distribution and the multiple contexts in which it has been isolated have suggested that its function may not be limited to IgE binding but may include a role in cell growth regulation and differentiation, neoplastic transformation, and cell adhesion (Liu, 1990, Crit. Rev. Immunol., 10:289–306; Barondes et al., 1994, J. Biol. Chem., 269:20807–20810). After immunoscreening of a λgt11 cDNA expression library made from bone-nodule forming cultures of fetal rat calvaria (RC) cells with an antibody raised against osteoblastic cells (Turksen et al., 1992, J. Histochem. Cytochem., 40:1339–1352), three cDNA clones were isolated and sequenced; the sequence matched that of rat galectin 3. Galectin 3 mRNA was detected in various fetal and adult rat tissues, including calvaria and cultured RC cells. In RC cells and the rat osteosarcoma cell line ROS 17/2.8, galectin 3 mRNA expression increased with time in culture, in contrast to its behavior in fetal rat skin fibroblasts (RSF) in which its expression decreased with time in culture. In a second rat osteosarcoma line, UMR 106.01, galectin 3 mRNA was almost nondetectable. The synthetic glucocorticoid dexamethasone (Dex) enhanced galectin 3 expression in RSF cell cultures, while 1,25-dihydroxyvitamin D3 (1,25(OH)2D3) had no significant effect. In contrast, Dex downregulated and 1,25(OH)2D3 upregulated galectin 3 expression in RC and ROS 17/2.8 cells, especially at later time points in culture when expression of osteoblast-associated differentiation markers by these cell types is most marked. Immunolabeling with an antibody against rat galectin 3 to identify galectin 3 protein showed that cells labelled within both the ROS 17/2.8 and RC populations but with marked intercellular heterogeneity of intensity. Our data support the conclusion that galectin 3 is a previously unrecognized product of osteoblastic cells, that galectin 3 mRNA and protein expression increases with time in vitro concomitant with other markers of osteogenesis, including formation of bone nodules and expression of osteoblast-associated markers such as alkaline phosphatase, bone sialo-protein, and osteocalcin, and that its expression is regulated by hormones such as glucocorticoids and 1,25(OH)2D3 that modulate other aspects of the osteoblast phenotype.Keywords
This publication has 50 references indexed in Scilit:
- β-Glycerophosphate-induced mineralization of osteoid does not alter expression of extracellular matrix components in fetal rat calvarial cell culturesJournal of Bone and Mineral Research, 1992
- Influence of dexamethasone on the vitamin D–mediated regulation of osteocalcin gene expressionJournal of Cellular Biochemistry, 1991
- The specific production of the third component of complement by osteoblastic cells treated with 1α,25‐dihydroxyvitamin D3FEBS Letters, 1991
- Continuously growing bipotential and monopotential myogenic, adipogenic, and chondrogenic subclones isolated from the multipotential RCJ 3.1 clonal cell lineDevelopmental Biology, 1990
- Factors that promote progressive development of the osteoblast phenotype in cultured fetal rat calvaria cellsJournal of Cellular Physiology, 1990
- The Mac-2 antigen is a galactose-specific lectin that binds IgE.Journal of Experimental Medicine, 1989
- Regulation of bone sialoprotein mRNA by steroid hormones.Journal of Cell Biology, 1989
- Ultrastructural analysis of bone nodules formed in vitro by isolated fetal rat calvaria cellsBone, 1988
- Carbohydrate-Specific Receptors of the LiverAnnual Review of Biochemistry, 1982
- Purification of Mouse Immunoglobulin Heavy‐Chain Messenger RNAs from Total Myeloma Tumor RNAEuropean Journal of Biochemistry, 1980